Search - tctmd.com

Displaying 821 - 840 of 2963

Sort: Relevancy | Date

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

Todd Neale

August 30, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Caitlin E. Cox

August 25, 2017

Presentation

Self-Expanding vs Balloon-Expandable Stents for Iliac Artery Occlusive Disease: ICE trial

August 25, 2017

News Daily News

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

Caitlin E. Cox

August 23, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

Yael L. Maxwell

August 16, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Yael L. Maxwell

August 07, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Daily News

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Caitlin E. Cox

July 28, 2017

News Industry News

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

July 25, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

Advertisement

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

ESC Updates Guidelines for Treating STEMI Patients

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Self-Expanding vs Balloon-Expandable Stents for Iliac Artery Occlusive Disease: ICE trial

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Boston Scientific Scraps Biodegradable Scaffold Program

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content